Perioperative Care of the Patient with Cancer
Therapeutic advances in cancer therapy have led to an increase in the number of patients undergoing surgery as part of their cancer treatment. These patients present several unique challenges, including weighing risks against adverse effects of delaying time-sensitive treatment and taking the patient’s cancer and its treatment into account when determining postoperative management. The following activity discusses these topics, with an emphasis on cardiovascular and pulmonary toxicities of radiation and chemotherapeutic agents as well as common hematologic problems encountered in patients with cancer or a history of cancer treatment.
Availability
On-Demand
Expires on Feb 22, 2027
Cost
Member: $0.00
Non-Member: $95.00
Credit Offered
2 CME Credits
2 ABIM-MOC Points
2 Participation Credits
  • Overview
  • Faculty
  • Accreditation
  • Recommended
Learning Objectives
After completing this activity, learners should be able to:
  1. Describe the cardiovascular toxicity of radiation and chemotherapeutic agents and unique cardiovascular risk considerations in the patient with cancer.
  2. Identify pulmonary toxicities of radiation and chemotherapy and their potential impact on perioperative management of the oncology patient.
  3. Describe common hematologic problems encountered in patients with cancer.
  4. Review other common adverse effects of chemotherapy and radiation therapy and organ-specific preoperative risk evaluation elements in patients with cancer.
  5. Anticipate and manage postoperative complications typical of the cancer patient population.
If you are a Program Director and would like to grant access to your trainees, please reach out to education@hospitalmedicine.org for an academic access code.
Faculty
  • Sunil K. Sahai, MD, FAAP, FACP, SFHM
  • Kurt Pfeifer, MD, FACP, SFHM, DFPM
  • Leonard Feldman, MD, FACP, FAAP, MHM

Faculty Disclosures
The faculty and planners of these activities have no relevant relationships to disclose. All relevant relationships were mitigated prior to the start of this activity.

Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this online activity for a maximum of 2.00 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to  2.00  MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IOS App Download Powered By